Home Health HLL Records 20% Revenue Growth; Reinforces Role in Affordable Healthcare

HLL Records 20% Revenue Growth; Reinforces Role in Affordable Healthcare

Shri J.P. Nadda
Shri J.P. Nadda

OCT 25: HLL Lifecare Limited (HLL), a Mini-Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, has paid a record dividend of ₹69.53 crore to the Government of India for the financial year 2024–25, one of the highest in its history.

The dividend cheque was presented to Union Health Minister Shri J.P. Nadda by Dr. Anitha Thampi, Chairperson of HLL, in the presence of Smt. Anupriya Patel, Minister of State for Health; Smt. Punya Salila Srivastava, Union Health Secretary; and other senior officials from the Ministry and HLL.

Commending HLL’s performance, Shri Nadda described the company as a reliable and integral part of India’s medical services, playing a key role in providing accessible, affordable, and quality healthcare. He noted that Amrit Pharmacies, operated by HLL and its subsidiaries, have served over 6.7 crore people in the past decade, helping citizens save more than ₹8,000 crore in out-of-pocket medical expenses.

HLL reported a 20% increase in operational revenue, reaching ₹4,500 crore in FY 2024–25, while its net worth rose to ₹1,100 crore. On a consolidated basis, including subsidiaries HITES, GAPL, and Lifespring Hospitals, total revenue reached ₹4,900 crore, marking 19% growth over the previous year.

Founded in 1966, HLL has evolved from a population control enterprise into a diversified healthcare leader, manufacturing medical products and managing healthcare facilities. Celebrating its 60th anniversary, HLL reaffirmed its mission to make healthcare more equitable, affordable, and high-quality across India.